Cannabinoid–Opioid Interaction in Chronic Pain

Cited by (319)

Items 101–200 of 319

1. Cannabis for Pain and Headaches: Primer
   Philip S. Kim, Michael Alan Fishman · 2017 · Current Pain and Headache Reports
2. The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report
   Howard Meng, John G. Hanlon, Rita Katznelson, Anand Ghanekar, Ian D. McGilvray, Hance A. Clarke · 2015 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
3. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans
   Shanna L. Babalonis, Michelle R. Lofwall, Paul A. Sloan, Paul A. Nuzzo, Laura C. Fanucchi, SHARON L. WALSH · 2019 · Psychopharmacology
4. A study of the neurotoxic effects of tramadol and cannabis in adolescent male albino rats
   Ola Elsayed Nafea, Iman Elkhishin, Othman A. Awad, Dalia A. Mohamed · 2016 · International Journal of Scientific Reports
5. Evaluation of potential drug–drug interactions with medical cannabis
   Jessie Jia Yi Ho, Chenyi Goh, Caitlin Shen Ai Leong, Khuen Yen Ng, Athirah Bakhtiar · 2024 · Clinical and Translational Science
6. Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State
   Kimberson Cochien Tanco, Donato Dumlao, Rebecca Kreis, Kristy Nguyen, Seyedeh S. Dibaj, Diane Liu, Vidyasagargoud Marupakula, Ayesha Hanin Shaikh, Walter F. Baile, Eduardo D Bruera · 2019 · Journal of Palliative Medicine
7. Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
   Bogdan-Ionel Tamba, Gabriela Dumitriţa Stanciu, Cristina Mariana Urîtu, Elena Rezuş, Raluca Ştefănescu, Cosmin Teodor Mihai, Andrei Luca, Gabriela Rusu-Zota, Maria Magdalena Leon, Elena Cojocaru et al. · 2020 · Medicina
8. Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
   James E. Barrett, Aryan Shekarabi, Saadet Inan · 2023 · Pharmacological Reviews
9. Re-Branding Cannabis: The Next Generation of Chronic Pain Medicine?
   Gregory T. Carter, Simone P. Javaher, Michael H. V. Nguyen, Sharon B. Garrett, Beatriz Helena Carlini · 2014 · Pain Management
10. Opioid-sparing effects of cannabinoids: Myth or reality?
    Bernard Le Foll · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
11. Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
    Ferenc Zádor, Maria Wollemann · 2015 · Pharmacological Research
12. The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance
    Jiebing Wen, Hefei Wen, J. S. Butler, Jeffery Talbert · 2021 · Health Economics
13. Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
    Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J.H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot et al. · 2023 · Cancers
14. No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: A 3‐month randomized study and 9‐month open‐treatment follow‐up study
    Zill-E-Huma Latif, Kristin Klemmetsby Solli, Arild Opheim, Nikolaj Kunøe, Jūratė Šaltytė Benth, Peter Krajči, Kamni Sharma‐Haase, Lars Tanum · 2019 · American Journal on Addictions
15. Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
    Aida Mohammadkhani, Stephanie L. Borgland · 2020 · Journal of Neuroscience Research
16. Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
    Brian Edward Perron, Kipling M. Bohnert, Angela K. Perone, Marcel O. Bonn‐Miller, Mark Andrew Ilgen · 2015 · Journal of Studies on Alcohol and Drugs
17. The role of cannabinoids in pain control: the good, the bad, and the ugly
    Joseph V. Pergolizzi, Jo Ann LeQuang, Robert Taylor, Robert B. Raffa, Daniel R. Colucci · 2018 · Minerva Anestesiologica
18. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling
    Anna Chiarlone, Christine Börner, Laura Martín-Gómez, Ada Jiménez-González, Adrián García-Concejo, Laura García‐Bermejo, Mar Lorente, Cristina Blázquez, Elena García-Taboada, Amador Haro et al. · 2016 · Neuropharmacology
19. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes
    Arya Shah, Julia R. Craner, Julie L. Cunningham · 2017 · Journal of Substance Abuse Treatment
20. Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB 1 and CB 2 receptors
    Xiaohong Chen, Alan Cowan, Saadet Inan, Ellen B. Geller, Joseph J. Meissler, Scott M. Rawls, Ronald J. Tallarida, Christopher S. Tallarida, Mia N. Watson, Martin W. Adler et al. · 2019 · British Journal of Pharmacology
21. Targeting the endogenous cannabinoid system to treat neuropathic pain
    Benjamin K. Lau, Christopher Walter Vaughan · 2014 · Frontiers in Pharmacology
22. Medical marijuana and pain management
    Leslie Mendoza Temple · 2016 · Disease-a-Month
23. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal
    Gerak, L.R., France, C.P. · 2016 · The Journal of Pharmacology and Experimental Therapeutics
24. Should Oncologists Recommend Cannabis?
    D. Abrams · 2019 · Current Treatment Options in Oncology
25. Peripherally Restricted Cannabinoids for the Treatment of Pain
    Edgar Alfonso Romero-Sandoval, Scott Asbill, Candler A. Paige, Kiara Byrd-Glover · 2015 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
26. Concomitant cannabis abuse/dependence in patients treated with opioids for non‐cancer pain
    Kathryn R. Hefner, Mehmet Sofuoglu, Robert Alan Rosenheck · 2015 · American Journal on Addictions
27. The effect of cannabis laws on opioid use
    Jamie L. Flexon, Lisa Stolzenberg, Stewart J. D’Alessio · 2019 · International Journal of Drug Policy
28. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys
    Lisa R. Gerak, Claudio Zanettini, Wouter Koek, Charles Patrick France · 2015 · Psychopharmacology
29. Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands
    Jing‐Fang Yang, Alexander H. Williams, Narsimha Reddy Penthala, Paul L. Prather, Peter Anthony Crooks, Chang‐Guo Zhan · 2020 · ACS Chemical Neuroscience
30. Subgroups of musculoskeletal pain patients and their psychobiological patterns – The LOGIN study protocol
    Andreas Gerhardt, Mechthild Hartmann, Jonas Tesarz, Susanne Janke, Sabine Leisner, Günter H. Seidler, Wolfgang Eich · 2012 · BMC Musculoskeletal Disorders
31. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
    Nicholas H. B. Schräder, Emily S. Gorell, Roy E. Stewart, José C. Duipmans, Nicole Harris, Victoria Aurora Ferrer Pérez, Jean Yuh Tang, André Paul Wolff, Maria C. Bolling · 2021 · Orphanet Journal of Rare Diseases
32. Cannabis-based medicines and the perioperative physician
    Patrick Tapley, Suzanne Kellett · 2019 · Perioperative Medicine
33. The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area
    Hong Zhang, Austin A. Lipinski, Erika Liktor‐Busa, Angela F. Smith, Aubin Moutal, Rajesh Khanna, Paul R. Langlais, Tally M. Largent‐Milnes, Todd W. Vanderah · 2021 · Frontiers in Pharmacology
34. A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome
    Tripp, Dean A, Nickel, J Curtis, Katz, Laura, Krsmanovic, Adrijana, Ware, Mark A, Santor, Darcy · 2014 · Canadian Urological Association Journal
35. Update on cannabis and cannabinoids for cancer pain
    Matthew J. Chung, Hee Kee Kim, Salahadin Abdi · 2020 · Current Opinion in Anaesthesiology
36. An Overview of Major and Minor Phytocannabinoids
    Jahan P. Marcu · 2016 · Elsevier eBooks
37. Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice
    Yang Yu, Quentin K. Tsang, Josue Jaramillo-Polanco, Alan E. Lomax, Stephen J. Vanner, David E. Reed · 2022 · Journal of Neuroscience
38. The endocannabinoid system: Novel targets for treating cancer induced bone pain
    Jia Sun, Ya‐Qun Zhou, Shuping Chen, Xiaomei Wang, Bingyang Xu, Danyang Li, Yuke Tian, Dawei Ye · 2019 · Biomedicine & Pharmacotherapy
39. The Medicinal Cannabis Treatment Agreement
    Barth L Wilsey, J. Hampton Atkinson, Thomas D. Marcotte, Igor Grant · 2014 · Clinical Journal of Pain
40. Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States
    Daniel E. Kaufman, Asawer M. Nihal, Janan D. Leppo, Kelly M. Staples, Kenneth L. McCall, Brian J. Piper · 2021 · Pharmacopsychiatry
41. Herb‐drug interactions: A short review on central and peripheral nervous system drugs
    João Bernardo, Patrı́cia Valentão · 2024 · Phytotherapy Research
42. Medication overuse headache in patients with chronic migraine using cannabis: A case–referent study
    Niushen Zhang, Yohannes Woubishet Woldeamanuel · 2021 · Headache The Journal of Head and Face Pain
43. Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within‐subject, randomized, placebo‐controlled laboratory study
    João Paulo De Aquino, Julia Meyerovich, Catherine Z. Xie, Mohini Ranganathan, Peggy A Compton, Brian P. Pittman, Michael Rogan, Mehmet Sofuoglu · 2023 · Addiction Biology
44. Priming primary care providers to engage in evidence-based discussions about cannabis with patients
    Devan L. Kansagara, William C. Becker, Chelsea K. Ayers, Jeanette M. Tetrault · 2019 · Addiction Science & Clinical Practice
45. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen, Gil Bar‐Sela · 2021 · Current Treatment Options in Oncology
46. Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine
    Lingjing Jin, Lizhen Pan, Yan Guo, Yu‐Guo Zheng, Zhiyu Nie, Rongrong Zhu · 2014 · Acta Neurobiologiae Experimentalis
47. Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data
    Hutchison, Kent E., Hagerty, Sarah L., Galinkin, Jeffrey, Bryan, Angela D., Bidwell, L. Cinnamon · 2019 · Cannabis & Cannabinoid Research
48. Cannabis for the Management of Cancer Symptoms: THC Version 2.0?
    Manuel Guzmán · 2018 · Cannabis and Cannabinoid Research
49. Translational value of non-human primates in opioid research
    Huiping Ding, Mei‐Chuan Ko · 2021 · Experimental Neurology
50. The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress
    Kara F. Manning, Andrew H. Rogers, Jafar Bakhshaie, Julianna Hogan, Julia D. Buckner, Joseph W. Ditre, Michael J. Zvolensky · 2018 · Addictive Behaviors
51. A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites
    Kevin M. Takakuwa, Dustin Sulak · 2020 · Cureus
52. Role of sex hormones in modulating breast and ovarian cancer associated pain
    Melissa C. McHann, Henry L. Blanton, Josée Guindon · 2021 · Molecular and Cellular Endocrinology
53. DNA Damaging Effects, Oxidative Stress Responses and Cholinesterase Activity in Blood and Brain of Wistar Rats Exposed to Δ9-Tetrahydrocannabinol
    Nevenka Kopjar, Nino Fuchs, Suzana Žunec, Anja Mikolić, Vedran Micek, Goran Kozina, Ana Lucić Vrdoljak, Irena Brčić Karačonji · 2019 · Molecules
54. Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
    Nadine Jagerovic, Cristina Fernández‐Fernández, Amaia Maite Erdozain, Rocı́o Girón, Eva Sánchez-Robles, José Antonio López‐Moreno, Paula Morales, Fernando Rodrı́guez de Fonseca, Pilar Goya, J. Javier Meana et al. · 2014 · Drug Design Development and Therapy
55. Complementary and Integrative Treatments
    Chau T. Nguyen, Marilene B. Wang · 2013 · Otolaryngologic Clinics of North America
56. Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice
    Rantaro Kamimura, Mohammad Zakir Hossain, Shumpei Unno, Hiroshi Ando, Yuji Masuda, Kojiro TAKAHASHI, Masanori Otake, Isao Saito, Junichi Kitagawa · 2018 · Journal of Oral Science
57. Antinociceptive and Abuse Potential Effects of Cannabinoid/Opioid Combinations in a Chronic Pain Model in Rats
    Mohammad Alsalem, Ahmad Altarifi, Mansour Haddad, Sara A. Aldossary, Heba Kalbouneh, Nour Aldaoud, Tareq Saleh, Khalid El‐Salem · 2019 · Brain Sciences
58. A Scoping Review of the Use of Cannabis and Its Extracts as Potential Harm Reduction Strategies: Insights from Preclinical and Clinical Research
    James Siklos-Whillans, Alia Bacchus, Laurie A. Manwell · 2020 · International Journal of Mental Health and Addiction
59. Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain
    Mohammad Alsalem, Ahmad Altarifi, Mansour Haddad, Belal Azab, Heba Kalbouneh, Amer Imraish, Tareq Saleh, Khalid El‐Salem · 2020 · Brain Sciences
60. Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms
    Hannah C. Huff, Archit Kumar Vasan, Pritam Roy, Aayush Kaul, Emad Tajkhorshid, Aditi Das · 2021 · Biochemistry
61. Use of oral cannabis extracts in the pediatric palliative care setting: A retrospective chart review
    Megan Doherty, Liam Power, Monica Attala, Christina M Vadeboncoeur · 2020 · Palliative Medicine
62. The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies
    Gabriel P. A. Costa, Julio Cesar Nunes, Daniel Lacerda Heringer, Akhil Anand, João Paulo De Aquino · 2024 · The American Journal of Drug and Alcohol Abuse
63. Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers
    Guohua Li, Stanford T. Chihuri · 2020 · Substance Abuse Treatment Prevention and Policy
64. Potencial uso terapéutico de cannabis
    Marcia Avello L, Edgar Pastene, Pola Fernández R, Pía Córdova Mariángel · 2017 · Revista médica de Chile
65. The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects
    Walid Shalata, Omar Abu Saleh, Lena Tourkey, Sondos Shalata, Ala Eddin Neime, Ali Abu‐Juma, Arina Soklakova, Lama Tourkey, Ashraf Abu Jama, Alexander Yakobson · 2024 · Cancers
66. An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
    Dolly Andrea Caicedo, Clara Pérez‐Mañá, Magı́ Farré, Esther Papaseit · 2025 · Pharmaceutics
67. Complementary and Alternative Medications for Chronic Pelvic Pain
    Fah Che Leong · 2014 · Obstetrics and Gynecology Clinics of North America
68. The Brainstem and Nociceptive Modulation
    Mary M. Heinricher, Susan Ingram · 2020 · Elsevier eBooks
69. The endocannabinoid system and breathing
    Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah, Tally M. Largent‐Milnes · 2023 · Frontiers in Neuroscience
70. A Pilot Study of a Medical Cannabis - Opioid Reduction Program
    Kevin Rod · 2019 · American Journal of Psychiatry and Neuroscience
71. Mechanisms of Pain in Sickle Cell Disease
    Anupam Aich, Alvin James Beitz, Kalpna Gupta · 2016 · InTech eBooks
72. Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.
    Tessa M. Frohe, Cheryl L. Beseler, Andres M Mendoza, Linda Bauer Cottler, Robert Francis Leeman · 2019 · Journal of Consulting and Clinical Psychology
73. Cannabis and the Cancer Patient
    Ilana Monica Braun, Donald I. Abrams, Stacey E Blansky, Steven A. Pergam · 2021 · JNCI Monographs
74. Considering Marijuana Legalization
    Jonathan P. Caulkins, Beau Kilmer, Mark A. R.Kleiman, Robert J. MacCoun, Greg Midgette, Pat Oglesby, Rosalie Liccardo Pacula, Peter Reuter · 2015
75. Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors
    Jessica M. Potts, Betelihem Getachew, Milkie Vu, Eric J. Nehl, Katherine A. Yeager, Corinne R. Leach, Carla J. Berg · 2020 · Journal of Cancer Education
76. High-intensity cannabis use and hospitalization: a prospective cohort study of street-involved youth in Vancouver, Canada
    Hudson Reddon, M‐J Milloy, Evan Wood, Ekaterina Nosova, Thomas H Kerr, Kora DeBeck · 2021 · Harm Reduction Journal
77. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain
    Stevie C. Britch, Rebecca M. Craft · 2021 · Behavioural Pharmacology
78. Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness
    Deanna Gek Koon Teoh, Thomas J. Smith, Mihae Song, Nick M. Spirtos · 2018 · American Society of Clinical Oncology Educational Book
79. The Effects of Medical Marijuana Laws on Prescribed Opioids and Other Prescription Drugs
    Pelin Ozluk · 2017 · SSRN Electronic Journal
80. Why Insurance Companies Should Pay for Medical Cannabis
    David Casarett, Donald I. Abrams · 2019 · The American Journal of Bioethics
81. Cys-loop receptors on cannabinoids: All high?
    Philip B. Schmiedhofer, Florian Daniel Vogel, Filip Koniuszewski, Margot Christiana Ernst · 2022 · Frontiers in Physiology
82. How the Incomplete Medicalization of Cannabis Shapes Patient Experiences
    Matt Reid · 2023 · Sociological Focus
83. Cannabinoids in dermatologic surgery
    Ha Eun Kong, Brian P. Pollack, Travis Wayne Blalock · 2021 · Journal of the American Academy of Dermatology
84. Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients
    Deena Damsky Dell, Daniel P. Stein, MD · 2021 · Journal of the Advanced Practitioner in Oncology
85. In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors
    Pankaj Pandey, Mallika Kumarihamy, Krishna Chaturvedi, Mohamed A. Ibrahim, Janet A. Lambert, Murrell Godfrey, Robert J. Doerksen, Ilias Muhammad · 2023 · Molecules
86. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys
    Lawrence M. Carey, David Richard Maguire, Charles Patrick France · 2023 · Drug and Alcohol Dependence
87. Molecular Pharmacology of CB1 and CB2 Cannabinoid Receptors
    Jahan P. Marcu, Jason B. Schechter · 2016 · Elsevier eBooks
88. Medical Cannabis Certification Is Associated With Decreased Opiate Use in Patients With Chronic Pain: A Retrospective Cohort Study in Delaware
    Alan Balu, Divya Mishra, Jahan P. Marcu, Ganesh Balu · 2021 · Cureus
89. A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
    Maria Wołyniak, Ewa Małecka-Wojciesko, Marta Zielińska, Adam Fabisiak · 2022 · Journal of Clinical Medicine
90. Cannabis Use Disorder Trends and Health Care Utilization After Cervical and Lumbar Spine Fusions
    Nicholas Edward Dietz, Victoria Alkin, Nitin Agarwal, Mayur Sharma, Brent G Oxford, Dengzhi Wang, Beatrice Ugiliweneza, Jersey Mettille, Maxwell Boakye, Doniel G. Drazin · 2023 · Spine
91. Treating Comorbid Opioid Use Disorder in Chronic Pain
    Annette M. Matthews, Jonathan C. Fellers · 2016 · Springer eBooks
92. Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence
    Débora Silva de Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu, João Paulo De Aquino · 2023 · International Review of Psychiatry
93. Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis
    Praveen Kumar Potukuchi, Hamid Moradi, Frank Park, Cameron M. Kaplan, Fridtjof Thomas, Ankur A. Dashputre, Keiichi Sumida, Miklos Zsolt Molnar, Abduzhappar Gaipov, Justin D. Gatwood et al. · 2021 · Cannabis and Cannabinoid Research
94. Sex-related differences in cannabidiol's antinociceptive efficacy in a trigeminal neuralgia rodent model
    Airam Nicole Vivanco-Estela, Sanderson Araujo da Rocha, Daniela Maria Escobar-Espinal, Gabriela Gonçalves Bálico, Robert M. Caudle, Francisco Silveira Guimarães, Elaine Del-Bel, Glauce Crivelaro Nascimento · 2025 · Pain
95. PON1 Q192R and Clopidogrel: A Case of the Winner’s Curse or Inadequate Replication?
    J A Talameh, Howard L. McLeod · 2011 · Clinical Pharmacology & Therapeutics
96. Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study
    Joanna L. Starrels, Sarah R Young, Soraya Azari, William C. Becker, Eva Jennifer Edelman, Jane M. Liebschutz, Jamie L. Pomeranz, Payel Jhoom Roy, Shalini Saini, Jessica S. Merlin · 2019 · Pain Medicine
97. Medical Marijuana in Patients Prescribed Opioids
    William C. Becker, Jeanette M. Tetrault · 2016 · Mayo Clinic Proceedings
98. Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis
    J. Briscoe, Arif H. Kamal, D. Casarett · 2019 · Journal of Palliative Medicine
99. Cannabis für medizinische Zwecke und seine ärztliche Verordnung
    Andreas Kiefer, Christiane Eckert-Lill, Daniela Bussick, Michael Hörnig, Holger Reimann · 2019 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
100. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study
     De Aquino, Joao P., Sofuoglu, Mehmet, Stefanovics, Elina A., Rosenheck, Robert A. · 2020 · The American Journal of Drug and Alcohol Abuse